Subsequently, we investigated whether pharmacological inhibition (JSH‐23) of NF‐κB, a critical regulator of E2F6, inhibits tumor growth and sensitizes TMZ in orthotopic patient‐derived GBM xenograft mouse model. The gene discussed is NFKB1; the disease is neoplasm.